# HEZQARA Phase 1–9 Reconciliation

| Phase | Status | Evidence |
|---|---|---|
| 1 Product UI & Experience | VERIFIED | Authenticated application shell, operational surfaces and truthful states exist. |
| 2 Design System & UX | VERIFIED | Shared navigation, tokens/primitives and accessibility patterns are used by governance UI. |
| 3 Operational Core | VERIFIED | Server-authoritative tenant → service → repository → PostgreSQL/RLS path remains canonical. |
| 4 AI Workforce & Automation | VERIFIED + E1 HARDENED | Workforce agents now fail closed without tenant governance; model output is re-evaluated before completion. |
| 5 Healthcare Workforce | VERIFIED | Patient communication, scheduling, consent and external-content boundaries remain in place. |
| 6 Healthcare Domain Engine | VERIFIED | Eligibility, billing, claims, authorization, referrals and administrative safety boundaries remain. |
| 7 Interoperability | VERIFIED | FHIR R4/provider boundary, webhook protection, SSRF boundary and deterministic test providers remain. |
| 8 Intelligence | VERIFIED | Deterministic analytics, canonical metrics, tracing and governed exports remain tenant scoped. |
| 9 AI Reliability & Governance | E1 IMPLEMENTED — VALIDATION GATE PENDING | Runtime enforcement, secondary AI-path governance, governed tool boundary, approval-backed side-effect authorization and adversarial tests are implemented on the E1 branch. CI must be fully green before this is declared verified. |

## E1 reconciliation findings fixed

- Closed the principal bypass in `AgentExecutor`: model execution now requires a tenant-scoped governance service.
- Added pre-model governance evaluation and post-output action/risk re-evaluation.
- Propagated governance context from the authenticated execution API into every workforce agent.
- Added tool allowlist enforcement in addition to existing user-permission checks.
- Added a reusable governed tool-call boundary.
- Added approval-backed side-effect authorization with execution, policy, action and expiry checks.
- Closed the secondary `MessageIntelligence` AI path behind the same governance boundary.
- Added adversarial tests for missing governance, pre-model denial, post-model approval gates, governed tool denial and clinical human-review enforcement.
- Preserved the existing API defense-in-depth policy/telemetry/audit path.

## Remaining roadmap

Phase 10 — production and enterprise hardening.
Phase 11 — scale, multi-clinic and platform infrastructure.
Phase 12 — commercial/enterprise productization.
Phase 13 — launch, growth and market expansion.

Phase status is an engineering status, not a regulatory certification.
